Salter-Cid Luisa
Insider CIK 1766404 · JNCE Director · GOSS Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 31,400 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 20,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 7,850 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-06-24 | 2022-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-06-18 | 2021-06-22 | 7,850 | — | $0 | 7,850 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2021-03-23 | 2021-03-25 | 5,491 | $9.48 | $52.1K | 206,065 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2021-02-25 | 2021-03-01 | 90,000 | — | $0 | 90,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2021-02-25 | 2021-03-01 | 45,000 | — | $0 | 211,556 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 31,400 | — | $0 | 31,400 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2020-02-14 | 2020-02-19 | 71,500 | — | $0 | 71,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2020-02-14 | 2020-02-19 | 46,500 | — | $0 | 166,556 | SEC↗ |
| GOSS Gossamer Bio, Inc. | G Gift | 2019-12-31 | 2020-01-02 | 4,000 | — | $0 | 120,056 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2019-08-29 | 2019-08-29 | 26,252 | $20.09 | $527.4K | 124,056 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2019-08-28 | 2019-08-29 | 23,748 | $19.65 | $466.6K | 150,308 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2019-03-25 | 2019-03-26 | 120,000 | — | $0 | 120,000 | SEC↗ |